Significance of cytomegalovirus for long-term survival after orthotopic liver transplantation: A prospective derivation and validation cohort analysis

Transplantation

Volumn 66, Issue 8, 1998, Pages 1020-1028

  Falagas, Matthew E ^b   Paya, Carlos ^b   Ruthazer, Robin ^b   Badley, Andrew ^b   Patel, Robin ^b   Wiesner, Russell ^b   Griffith, John ^b   Freeman, Richard ^b   Rohrer, Richard ^b   Werner, Barbara G ^b   Snydman, David R ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CORRELATION FUNCTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; GRAFT SURVIVAL; HUMAN; INFECTION RISK; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; COHORT STUDIES; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FORECASTING; HUMANS; LIVER TRANSPLANTATION; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0032573043     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199810270-00010     Document Type: Article

References (44)

1. Rubin RH. Infection in the organ transplant recipient. In: Rubin RH, Young LS, eds. Clinical approach to infection in the immunocompromised host, 3rd ed. New York: Plenum Medical Book, 1994: 647.
2. Stratta RJ, Shaefer MS, Markin RS, et al. Clinical patterns of cytomegalovirus disease after liver transplantation. Arch Surg 1989; 124: 1443.
3. Wiesner RH, Marin E, Porayko MK, Steers JL, Krom RAF, Paya CV. Advances in liver transplantation. Gastroenterol Clin North Am 1993; 22: 351.
4. Collins LA, Samore MH, Roberts MS, et al. Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis 1994; 170: 644.
5. Paya CV, Wiesner RH, Hermans PE, et al. Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis. J Hepatol 1993; 18: 185.
6. George MJ, Snydman DR, Werner BG, et al. The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Am J Med 1997; 103: 106.
7. Falagas ME, Snydman DR, Griffith J, Werner B, CMVIG Study Group. Exposure to cytomegalovirus from the donated organ is a risk factor for bacteremia in orthotopic liver transplant recipients. Clin Infect Dis 1996; 23: 468.
8. Rand KH, Pollard RB, Merigan TC. Increased pulmonary super-infections in cardiac-transplant patients undergoing primary cytomegalovirus infection. N Engl J Med 1978; 298: 951.
9. Gorensek MJ, Stewart RW, Keys TF, McHenry MC, Babiak T, Goormastic M. Symptomatic cytomegalovirus infection as a significant risk factor for major infections after cardiac transplantation. J Infect Dis 1988; 158: 884.
10. Reinke P, Fietze E, Ode-Hakim S, et al. Late-acute renal allograft rejection and symptomless cytomegalovirus infection. Lancet 1994; 344: 1737.
11. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261: 3561.
12. Bando K, Paradis IL, Komatsu K, et al. Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation. J Thorac Cardiovasc Surg 1995; 109: 49.
13. Ettinger NA, Bailey TC, Trulock EP, et al. Cytomegalovirus infection and pneumonitis: impact after isolated lung transplantation. Am Rev Respir Dis 1993; 147: 1017.
14. Mirata M, Terasaki PI, Cho YW. Cytomegalovirus antibody status and renal transplantation: 1987-1994. Transplantation 1996; 62: 34.
15. Todo S, Fung JJ, Starzl TE, et al. Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. Ann Surg 1994; 220: 297.
16. Nikaein A, Backman L, Jennings L, et al. HLA compatibility and liver transplant outcome. Transplantation 1994; 58: 786.
17. Delmonico FL, Jenkins RL, Freeman R, et al. The high-risk liver allograft recipient: should allocation policy consider outcome? Arch Surg 1992; 127: 579.
18. Adler M, Gavaler JS, Duquesnoy R, et al. Relationship between the diagnosis, preoperative evaluation, and prognosis after orthotopic liver transplantation. Ann Surg 1988; 208: 196.
19. Muto P, Freeman RB, Haug CE, Lu A, Rohrer RJ. Liver transplant candidate stratification systems: implications for third-party payors and organ allocation. Transplantation 1994; 57: 306.
20. Roberts MS, Pinson CW, Karlson C, Stone M, Rohrer R, Jenkins JL. Predictors of intraoperative death and long-term survival in liver transplantation: a multistage analysis. Transplant Proc 1989; 21: 2439.
21. Motschman TL, Taswell HF, Brecher ME, et al. Intraoperative blood loss and patient and graft survival in orthotopic liver transplantation: their relationship to clinical and laboratory data. Mayo Clin Proc 1989; 64: 346.
22. Mor E, Jennings L, Gonwa TA, et al. The impact of operative bleeding on outcome in transplantation of the liver. Surg Gynecol Obstet 1993; 176: 219.
23. Kahn D, Gavaler JS, Makowka L, Van Thiel DH. Gender of donor influences outcome after orthotopic liver transplantation in adults. Digest Dis Sci 1993; 38: 1485.
24. Lo CM, Shaked A, Busuttil RW. Risk factors for liver transplantation across the ABO barrier. Transplantation 1994; 58: 543.
25. Busuttil RW, Colonna JO, Hiatt JR, et al. The first 100 liver transplants at UCLA. Ann Surg 1987; 206: 387.
26. Baliga P, Merio RM, Turcotte JG, et al. Preoperative risk factor assessment in liver transplantation. Surgery 1992; 112: 704.
27. Cuervas-Mons V, Millan I, Gavaler JS, Starzl TE, Van Thiel DH. Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation. Hepatology 1986; 6: 922.
28. Gonwa TA, Klintmalm GB, Levy M, Jennings LS, Goldstein RM, Husberg BS. Impact of pretransplant renal function on survival after liver transplantation. Transplantation 1995; 59: 361.
29. Rimola A, Gavaler JS, Schade RR, El-Lankany S, Starzl TE, Van Thiel DH. Effects of renal impairment on liver transplantation. Gastroenterology 1987; 93: 148.
30. Pikul J, Sharpe MD, Lowndes R, Ghent CN. Degree of preoperative malnutrition in predictive of postoperative morbidity and mortality in liver transplant recipients. Transplantation 1994; 57: 469.
31. Stratta RJ, Shaeffer MS, Markin RS, et al. Cytomegalovirus infection and disease after liver transplantation. Digest Dis Sci. 1992; 37: 673.
32. Busson M, N'Doye P, Benoit G, et al. Donor factors influencing organ transplant prognosis. Transplant Proc 1995; 27: 1662.
33. Falagas ME, Snydman DR, Griffith J, et al. Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. Ann Intern Med 1997; 126: 275.
34. Snydman DR, Werner BG, Dougherty NN, Boston Center for Liver Transplantation CMVIG-Study Group. Cytomegalovirus immune globulin prophylaxis in liver transplantation: a randomized, double-blind, placebo controlled trial. Ann Intern Med 1993; 119: 984.
35. Snydman DR, Werner BG, Dougherty NN, et al. A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Transplant Proc 1994; 26 (suppl 1): 23.
36. Badley AD, Patel R, Portela DF, et al. Prognostic significance and risk factors of untreated cytomegalovirus viremia in liver transplant recipients. J Infect Dis 1995; 173: 446.
37. Falagas ME, Snydman DR, Ruthazer R, Boston Center for Liver Transplantation CMVIG Study Group. The incidence and predictors of cytomegalovirus pneumonia in orthotopic liver transplant recipients. Transplantation 1996; 61: 1716.
38. SAS Institute Inc. SAS/STAT user's guide, version 6, 4th ed. Cary, NC: SAS Institute Inc., 1990.
39. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29.
40. United Network for Organ Sharing (UNOS). 1994 report of center specific graft and patient survival rates (liver volume) Richmond, VA: UNOS, 1994.
41. Winston DJ, Wirin D, Shaked A, Busuttil RW. Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients. Lancet 1995; 346: 69.
42. Badley AD, Seaberg EC, Porayko MK, et al. Prophylaxis of cytomegalovirus infection in liver transplantation: a randomized trial comparing a combination of ganciclovir and acyclovir to acyclovir. Transplantation 1997; 64: 66.
43. Falagas ME, Snydman DR, Ruthazer R, et al. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. Clin Transplant 1997; 11: 432.
44. Gane E, Saliba F, Valdecasas GJC, et al. Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. Lancet 1997; 350: 1729.